Reuters logo
BRIEF-Denmark's Novo Nordisk will not turn into big M&A machine-CEO
March 23, 2017 / 2:04 PM / in 7 months

BRIEF-Denmark's Novo Nordisk will not turn into big M&A machine-CEO

March 23 (Reuters) - The CEO of Novo Nordisk‘s, the world’s biggest diabetes company, made the following comments at the firm’s annual general meeting on Thursday:

* “Some have speculated that Novo Nordisk will turn into a big M&A machine. That will not happen,” said Lars Fruergaard Joergensen

* “I can confirm that we will be looking more at external innovation”

* He repeated that the company is also looking at bolt-on acquisitions

* “Yes we are looking, but it will not turn Novo Nordisk into a different company”

* Fruergard has previously said the firm is looking at making acquisitions to broaden the drugmaker’s product line-up, in a change of tack that reflects a need for fresh sources of growth Further company coverage: (Reporting By Stine Jacobsen, editing by Gwladys Fouche)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below